HaTay Pharmaceutical JSC

HaTay Pharmaceutical JSC Net Margin

The Net Profit Margin of HaTay Pharmaceutical JSC (DHT.VN) as of Nov 3, 2026 is 3.44 %. In the previous year, Net Profit Margin was 4.25 % — a change of -19.14% (lower).

Net Margin

3.44 %

YoY

-19.14%

Last updated:

Net Profit Margin of HaTay Pharmaceutical JSC is 2024 3.44 % . Net Profit Margin of HaTay Pharmaceutical JSC was 2023 4.25 % . It decreases by -19.14% lower compared to the previous year.

For HaTay Pharmaceutical JSC, the net margin of 3.4% is down versus 4.6% a few years ago.

The HaTay Pharmaceutical JSC Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2017
4.87 VND
Jan 1, 2018
4.75 VND
Jan 1, 2019
4.22 VND
Jan 1, 2020
4.59 VND
Jan 1, 2021
4.22 VND
Jan 1, 2022
5.18 VND
Jan 1, 2023
4.25 VND
Jan 1, 2024
3.44 VND
The HaTay Pharmaceutical JSC Net Margin history
YEARNet MarginYoY
3.44 %-19.14%
4.25 %-17.90%
5.18 %+22.74%
4.22 %-7.97%
4.59 %+8.64%
4.22 %-11.19%
4.75 %-2.43%
4.87 %+17.41%
4.15 %+13.64%
3.65 %+13.90%
3.21 %+8,803.28%
0.04 %+65.71%
0.02 %-18.38%
0.03 %-6.18%
0.03 %+15.85%
0.02 %+25.68%
0.02 %-7.10%
0.02 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

HaTay Pharmaceutical JSC Stock analysis

What does HaTay Pharmaceutical JSC do? Ha Tay Pharmaceutical JSC generates revenue through the manufacturing, import, and export of pharmaceuticals, cosmetics, and medical equipment. The company sells its products via wholesale and retail channels, targeting healthcare providers, pharmacies, and consumers. It also engages in the production and trading of cosmetic products, supplemental food, and laboratory chemicals, alongside medical equipment and supplies. The firm completed the acquisition of a 50.626% stake in Ha Tay Pharmaceutical and Medical Equipments Joint Stock Company in 2013, expanding its market presence in pharmaceuticals and medical equipment. The company operates in the pharmaceutical sector, serving healthcare institutions, retail pharmacies, and end consumers. Its revenue streams include the sale of drugs, cosmetics, medical equipment, and related supplies. Additional income comes from supermarket operations, real estate leasing, and vocational training services, though these are secondary to its core pharmaceutical business. Ha Tay Pharmaceutical JSC's primary customers are healthcare providers, pharmacies, and consumers purchasing pharmaceuticals, cosmetics, and medical equipment. The firm's product portfolio spans drugs, vaccines, cosmetic products, supplemental food, and laboratory chemicals, with a focus on manufacturing and trading. The acquisition of the 50.626% stake in Ha Tay Pharmaceutical and Medical Equipments Joint Stock Company has strengthened its position in the medical equipment market. HaTay Pharmaceutical JSC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about HaTay Pharmaceutical JSC stock

Net Profit Margin of HaTay Pharmaceutical JSC is 3.44 % in 2024.

Net Profit Margin of HaTay Pharmaceutical JSC changed from 4.25 % to 3.44 %, representing a -19.14% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin HaTay Pharmaceutical JSC since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's HaTay Pharmaceutical JSC with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — HaTay Pharmaceutical JSC

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — HaTay Pharmaceutical JSC